open access

Vol 3, No 4 (2014)
Original articles (submitted)
Published online: 2014-09-22
Get Citation

Is smoking a risk factor for metabolic syndrome?

Ivana Dedinska, Ľudovít Laca, Juraj Miklušica, Blažej Palkoci, Jurina Sadloňová, Peter Galajda, Marián Mokáň
Diabetologia Kliniczna 2014;3(4):136-143.

open access

Vol 3, No 4 (2014)
Original articles (submitted)
Published online: 2014-09-22

Abstract

Background. We define metabolic syndrome as a non-random collective incidence of glucose metabolism disorders related to insulin resistance, central obesity, dyslipidemia, arterial hypertension and other factors which contribute to increased risk of ischemic heart disease and diabetes mellitus type 2. Smoking is one of the most significant risk factors for ischemic heart disease.

Objectives and methods. A prospective analysis of 125 patients (75 men and 50 women) with the averageage of 57.3 years. A subset of smokers was composed of 59 patients; the average number of cigarettes smoked per day was 18 pieces. A subset of non-smokers was composed of 66 patients. We examined the presence of metabolic syndrome components according to the International Diabetic Federation criteria for the European population throughout the whole set of patients.

Results. Percentually higher incidence of metabolic syndrome occurred in the group of non-smokers. The incidence of metabolic syndrome in the group of smokers was significantly influenced by their age. Arterial hypertension and impaired fasting glucose were the most frequent components of metabolic syndrome in the subset of smokers with metabolic syndrome. In the subset of non-smokers with metabolic syndrome arterial hypertension was the most frequently found component.

Conclusion. The results of the research did not show statistically significantly increased or decreased incidence of metabolic syndrome in case of smokers. We did not find any relation between the number of cigarettes smoked per day and metabolic syndrome development.

Abstract

Background. We define metabolic syndrome as a non-random collective incidence of glucose metabolism disorders related to insulin resistance, central obesity, dyslipidemia, arterial hypertension and other factors which contribute to increased risk of ischemic heart disease and diabetes mellitus type 2. Smoking is one of the most significant risk factors for ischemic heart disease.

Objectives and methods. A prospective analysis of 125 patients (75 men and 50 women) with the averageage of 57.3 years. A subset of smokers was composed of 59 patients; the average number of cigarettes smoked per day was 18 pieces. A subset of non-smokers was composed of 66 patients. We examined the presence of metabolic syndrome components according to the International Diabetic Federation criteria for the European population throughout the whole set of patients.

Results. Percentually higher incidence of metabolic syndrome occurred in the group of non-smokers. The incidence of metabolic syndrome in the group of smokers was significantly influenced by their age. Arterial hypertension and impaired fasting glucose were the most frequent components of metabolic syndrome in the subset of smokers with metabolic syndrome. In the subset of non-smokers with metabolic syndrome arterial hypertension was the most frequently found component.

Conclusion. The results of the research did not show statistically significantly increased or decreased incidence of metabolic syndrome in case of smokers. We did not find any relation between the number of cigarettes smoked per day and metabolic syndrome development.

Get Citation

Keywords

metabolic syndrome, smoking, nicotine, obesity, cardiovascular risk

About this article
Title

Is smoking a risk factor for metabolic syndrome?

Journal

Clinical Diabetology

Issue

Vol 3, No 4 (2014)

Pages

136-143

Published online

2014-09-22

Bibliographic record

Diabetologia Kliniczna 2014;3(4):136-143.

Keywords

metabolic syndrome
smoking
nicotine
obesity
cardiovascular risk

Authors

Ivana Dedinska
Ľudovít Laca
Juraj Miklušica
Blažej Palkoci
Jurina Sadloňová
Peter Galajda
Marián Mokáň

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl